LISA COCO: Open Payments
NPI 1841203726 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$42,154 in 125 payments from 20 companies in 2025. Trend: 2023 $30,189 · 2024 $12,430 · 2025 $42,154
Speaker / faculty: $22,017Travel & lodging: $8,531Honoraria: $8,484Food & beverage: $3,123
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 32 | $25,078 |
| Xeris Pharmaceuticals, Inc. | 34 | $13,173 |
| GlaxoSmithKline, LLC. | 7 | $2,561 |
| Abbott Laboratories | 10 | $336 |
| Amgen Inc. | 12 | $249 |
| Lilly USA, LLC | 12 | $166 |
| Ascendis Pharma Endocrinology Inc | 2 | $139 |
| Medtronic, Inc. | 1 | $119 |
| Corcept Therapeutics | 2 | $42 |
| Amphastar Pharmaceuticals, Inc. | 2 | $39 |
Products named: Ozempic, GVOKE HYPOPEN, AREXVY, FREESTYLE LIBRE 3, Yorvipath, MINIMED 780G, EVENITY, TEPEZZA.
Industry payments across PA — which companies pay providers there.
